- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有20家主力机构披露2025-06-30报告期持股数据，持仓量总计1.66亿股，占流通A股31.60%
- 波段诊断：
-
技术面诊股
诊断结果：5.5技术面打败了63%的股票
技术面评分前10的股票
近期的平均成本为8.80元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为8.80元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.80","date":1773908457,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2026.03.20","stock":"-3.55","trade":null,"ind":"-1.24"},{"date":"2026.03.19","stock":"-1.31","trade":null,"ind":"-1.39"},{"date":"2026.03.18","stock":"3.51","trade":null,"ind":"0.32"},{"date":"2026.03.17","stock":"-1.01","trade":null,"ind":"-0.85"},{"date":"2026.03.16","stock":"0.79","trade":null,"ind":"-0.26"},{"date":"2026.03.13","stock":"0.00","trade":null,"ind":"-0.81"},{"date":"2026.03.12","stock":"-2.43","trade":null,"ind":"-0.10"},{"date":"2026.03.11","stock":"-1.20","trade":null,"ind":"0.25"},{"date":"2026.03.10","stock":"0.66","trade":null,"ind":"0.65"},{"date":"2026.03.09","stock":"2.47","trade":null,"ind":"-0.67"},{"date":"2026.03.06","stock":"3.73","trade":null,"ind":"0.38"},{"date":"2026.03.05","stock":"0.12","trade":null,"ind":"0.64"},{"date":"2026.03.04","stock":"-0.12","trade":null,"ind":"-0.98"},{"date":"2026.03.03","stock":"-4.35","trade":null,"ind":"-1.43"},{"date":"2026.03.02","stock":"-4.27","trade":null,"ind":"0.47"},{"date":"2026.02.27","stock":"4.00","trade":null,"ind":"0.39"},{"date":"2026.02.26","stock":"-0.77","trade":null,"ind":"-0.01"},{"date":"2026.02.25","stock":"1.68","trade":null,"ind":"0.72"},{"date":"2026.02.24","stock":"2.06","trade":null,"ind":"0.87"},{"date":"2026.02.13","stock":"-2.24","trade":null,"ind":"-1.26"},{"date":"2026.02.12","stock":"-0.33","trade":null,"ind":"0.05"}]
济民健康,上证指数,医疗器械指数
压力支撑
该股压力位为8.82元，支撑位为8.58元。
[{"text":"\u538b\u529b\u4f4d","value":"8.82","date":1773936000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.58","date":1773936000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.6资金面打败了66%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月20日 20:31
| 机构今日流向(万元) | -1037.05 | 机构5日流向(万元) | -3430.83 |
| 机构10日流向(万元) | -4924.14 | 机构20日流向(万元) | -10384.97 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少680.31万股，其中基金净减仓5家，主力净减仓12家，请投资者中长期谨慎为宜。
截止2025-06-30，共20家主力机构（基金16家，一般法人4家），持仓量总计16592.12万股，占流通A股31.60%
其中，基金持仓与2024-12-31相比：
增仓：4家 ，增持 4.26万股
减仓：9家 ，减持 18.40万股
新出现在主力名单中：4家 ，持有366.47万股
从主力名单中消失：16家 ，原持有1027.39万股
其中，基金持仓与2024-12-31相比：
增仓：4家 ，增持 4.26万股
减仓：9家 ，减持 18.40万股
新出现在主力名单中：4家 ，持有366.47万股
从主力名单中消失：16家 ，原持有1027.39万股
消息面诊股
诊断结果：4.7消息面打败了18%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 济民健康：3月19日获融资买入729.66万元
2026-03-20 - A股股票回购一览：15家公司披露回购进展
2026-03-20 - 济民健康：累计回购公司股份11645140股
2026-03-19 - 1.83亿关联增资入局，济民健康为亏损子公司“输血
2026-03-19 - 济民健康全资子公司鄂州二院拟引入战投长河军民创新
2026-03-19 - 济民健康：3月18日获融资买入3423.32万元
2026-03-19 - 中国团队实现再生胰岛微创移植，创新药概念再度活跃
2026-03-18 - 创新药板块震荡上扬，中源协和涨停
2026-03-18 - 济民健康：3月17日获融资买入316.20万元
2026-03-18 - 济民健康：子公司鄂州二院获1.83亿元增资
2026-03-17
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-03-18 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-18 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-18 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-03-07 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-24 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-01 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-21 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-29 |
| 一般消息 | 高管变动 | 涉嫌伪造公司印章罪 | 2025-03-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了8%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.20","price":"-1.24","value":null},{"date":"2026.03.19","price":"-1.39","value":null},{"date":"2026.03.18","price":"0.32","value":null},{"date":"2026.03.17","price":"-0.85","value":null},{"date":"2026.03.16","price":"-0.26","value":null},{"date":"2026.03.13","price":"-0.81","value":null},{"date":"2026.03.12","price":"-0.10","value":null},{"date":"2026.03.11","price":"0.25","value":null},{"date":"2026.03.10","price":"0.65","value":null},{"date":"2026.03.09","price":"-0.67","value":null},{"date":"2026.03.06","price":"0.38","value":null},{"date":"2026.03.05","price":"0.64","value":null},{"date":"2026.03.04","price":"-0.98","value":null},{"date":"2026.03.03","price":"-1.43","value":null},{"date":"2026.03.02","price":"0.47","value":null},{"date":"2026.02.27","price":"0.39","value":null},{"date":"2026.02.26","price":"-0.01","value":null},{"date":"2026.02.25","price":"0.72","value":null},{"date":"2026.02.24","price":"0.87","value":null},{"date":"2026.02.13","price":"-1.26","value":null},{"date":"2026.02.12","price":"0.05","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 九安医疗 | 48.80% | 12.75% | 5.4分 |
| 2 | 英科医疗 | 40.04% | -9.16% | 5.2分 |
| 3 | 蓝帆医疗 | 34.25% | 2.77% | 5.5分 |
| 4 | 中源协和 | 17.80% | 1.32% | 4.9分 |
| 5 | 爱迪特 | 13.44% | -16.25% | 4.7分 |
| 6 | 康拓医疗 | 12.27% | 2.45% | 6.4分 |
| 8 | 基蛋生物 | 10.16% | 15.57% | 5.3分 |
| 10 | 英诺特 | 8.93% | -1.36% | 5.0分 |
| 12 | 心脉医疗 | 7.00% | -2.03% | 5.3分 |
| 14 | 振德医疗 | 5.84% | 0.39% | 6.2分 |
| 16 | 南卫股份 | 5.11% | -4.90% | 5.3分 |
| 18 | 康众医疗 | 2.35% | -4.02% | 4.2分 |
| 20 | 三鑫医疗 | 1.61% | -6.97% | 4.6分 |
| 22 | 万泰生物 | -0.72% | 1.08% | 4.8分 |
| 24 | 冠昊生物 | -1.54% | -4.53% | 5.0分 |
| 26 | 惠泰医疗 | -2.14% | -1.43% | 5.9分 |
| 28 | 理邦仪器 | -2.46% | -3.12% | 5.7分 |
| 30 | ST凯利 | -2.76% | -3.39% | 4.9分 |
| 32 | 美康生物 | -2.85% | -3.14% | 4.4分 |
| 34 | - | -3.33% | -4.68% | 分 |
| 36 | 威高骨科 | -3.48% | -10.05% | 5.1分 |
| 38 | 采纳股份 | -3.81% | -10.83% | 4.2分 |
| 40 | 新华医疗 | -4.30% | -4.24% | 4.4分 |
| 42 | 健尔康 | -4.82% | -2.29% | 4.7分 |
| 44 | 圣湘生物 | -4.91% | 1.64% | 5.5分 |
| 46 | 国发股份 | -5.28% | -0.16% | 4.7分 |
| 48 | 安图生物 | -5.57% | -1.69% | 5.2分 |
| 50 | 伟思医疗 | -5.69% | -14.53% | 5.0分 |
| 52 | 迈克生物 | -5.92% | -2.97% | 4.0分 |
| 54 | 正海生物 | -6.04% | -5.02% | 4.2分 |
| 56 | 山东药玻 | -6.19% | -2.55% | 4.7分 |
| 58 | 科美诊断 | -6.31% | -3.58% | 4.2分 |
| 60 | 威高血净 | -6.48% | -3.59% | 5.6分 |
| 62 | 奥泰生物 | -6.83% | -2.54% | 4.8分 |
| 64 | 浩欧博 | -6.90% | -2.93% | 5.3分 |
| 66 | 尚荣医疗 | -7.11% | -7.11% | 4.7分 |
| 68 | 利德曼 | -7.41% | -5.11% | 4.6分 |
| 70 | 奕瑞科技 | -7.75% | -3.12% | 5.6分 |
| 72 | 万东医疗 | -7.92% | -1.88% | 5.1分 |
| 74 | 奥精医疗 | -8.03% | -8.64% | 5.4分 |
| 76 | 海利生物 | -8.16% | -7.41% | 3.6分 |
| 78 | 五洲医疗 | -8.45% | -1.95% | 4.4分 |
| 80 | 正川股份 | -8.65% | -6.16% | 4.6分 |
| 82 | 九强生物 | -8.73% | -4.30% | 3.5分 |
| 84 | 健帆生物 | -8.93% | -3.08% | 4.0分 |
| 86 | 之江生物 | -9.32% | -4.02% | 4.0分 |
| 88 | 天智航 | -9.34% | -4.96% | 4.5分 |
| 90 | 仁度生物 | -9.61% | -7.53% | 5.4分 |
| 92 | 迈瑞医疗 | -9.83% | -5.07% | 4.8分 |
| 94 | 易瑞生物 | -10.40% | -7.76% | 4.8分 |
| 96 | 康泰医学 | -10.67% | -4.14% | 4.6分 |
| 98 | 大博医疗 | -10.92% | -5.20% | 4.6分 |
| 100 | 博拓生物 | -11.07% | -8.28% | 4.4分 |
| 102 | 三诺生物 | -11.61% | -3.91% | 5.0分 |
| 104 | 澳华内镜 | -11.73% | -5.15% | 3.9分 |
| 106 | 透景生命 | -11.91% | -6.33% | 3.2分 |
| 108 | 西山科技 | -12.15% | -5.63% | 4.8分 |
| 110 | - | -12.45% | -7.32% | 分 |
| 112 | 睿昂基因 | -12.57% | -8.41% | 3.9分 |
| 114 | 港通医疗 | -13.08% | -9.18% | 4.3分 |
| 116 | 硕世生物 | -13.18% | -7.76% | 4.1分 |
| 118 | 力诺药包 | -13.46% | -13.46% | 4.3分 |
| 120 | 春立医疗 | -13.92% | -4.99% | 5.6分 |
| 122 | 安必平 | -14.48% | -7.63% | 4.3分 |
| 124 | 麦克奥迪 | -14.92% | -6.59% | 4.5分 |
| 126 | 康为世纪 | -15.00% | -7.42% | 3.7分 |
| 128 | 山外山 | -15.13% | -6.71% | 5.4分 |
| 130 | - | -16.22% | -9.57% | 分 |
| 132 | 热景生物 | -17.95% | -8.62% | 3.5分 |
| 134 | 海泰新光 | -19.21% | -2.07% | 5.5分 |
| 136 | 福瑞医科 | -21.82% | -2.51% | 5.0分 |
| 138 | 华大智造 | -22.05% | -4.13% | 4.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 124/243 ， 96/243。
[{"date":"2025-09-30","value":"-5.36","vol":"2.98"},{"date":"2025-06-30","value":"-3.63","vol":"2.34"},{"date":"2025-03-31","value":"-0.93","vol":"1.16"},{"date":"2024-12-31","value":"-3.91","vol":"0.56"},{"date":"2024-09-30","value":"1.80","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-5.36 | -3.63 | -0.93 | -3.91 | 1.80 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"36.11","vol":"51.74"},{"date":"2025-06-30","value":"36.87","vol":"52.05"},{"date":"2025-03-31","value":"37.63","vol":"51.42"},{"date":"2024-12-31","value":"37.31","vol":"52.52"},{"date":"2024-09-30","value":"43.25","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
36.11 | 36.87 | 37.63 | 37.31 | 43.25 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 113/243 ， 127/243。
[{"date":"2025-09-30","value":"-20.21","vol":"0.26"},{"date":"2025-06-30","value":"-21.30","vol":"-1.09"},{"date":"2025-03-31","value":"-22.49","vol":"-0.12"},{"date":"2024-12-31","value":"-13.28","vol":"1.15"},{"date":"2024-09-30","value":"0.74","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-20.21 | -21.30 | -22.49 | -13.28 | 0.74 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-371.51","vol":"-15.37"},{"date":"2025-06-30","value":"-307.10","vol":"-18.14"},{"date":"2025-03-31","value":"-191.72","vol":"-2.59"},{"date":"2024-12-31","value":"8.81","vol":"-23.09"},{"date":"2024-09-30","value":"-36.96","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-371.51 | -307.10 | -191.72 | 8.81 | -36.96 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 71/243 ， 27/243。
[{"date":"2025-09-30","value":"0.22","vol":"0.25"},{"date":"2025-06-30","value":"0.15","vol":"0.17"},{"date":"2025-03-31","value":"0.07","vol":"0.08"},{"date":"2024-12-31","value":"0.32","vol":"0.36"},{"date":"2024-09-30","value":"0.28","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.22 | 0.15 | 0.07 | 0.32 | 0.28 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.26","vol":"1.66"},{"date":"2025-06-30","value":"1.43","vol":"1.12"},{"date":"2025-03-31","value":"0.65","vol":"0.55"},{"date":"2024-12-31","value":"3.16","vol":"2.32"},{"date":"2024-09-30","value":"2.66","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.26 | 1.43 | 0.65 | 3.16 | 2.66 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"2.16","vol":"14.74"},{"date":"2025-06-30","value":"-38.08","vol":"15.17"},{"date":"2025-03-31","value":"19.07","vol":"4.22"},{"date":"2024-12-31","value":"30.84","vol":"29.38"},{"date":"2024-09-30","value":"1.18","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 2.16 | -38.08 | 19.07 | 30.84 | 1.18 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.47","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.01","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.47 | - | 1.01 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/243 ， 12/243。
[{"date":"2025-09-30","value":"1.03","vol":"5.66"},{"date":"2025-06-30","value":"1.06","vol":"5.47"},{"date":"2025-03-31","value":"1.33","vol":"5.84"},{"date":"2024-12-31","value":"1.47","vol":"5.30"},{"date":"2024-09-30","value":"1.58","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.03 | 1.06 | 1.33 | 1.47 | 1.58 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.81","vol":"4.51"},{"date":"2025-06-30","value":"0.82","vol":"4.35"},{"date":"2025-03-31","value":"1.06","vol":"4.73"},{"date":"2024-12-31","value":"1.08","vol":"4.27"},{"date":"2024-09-30","value":"1.11","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.81 | 0.82 | 1.06 | 1.08 | 1.11 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 9/243 ， 11/243。
[{"date":"2025-09-30","value":"40.38","vol":"22.07"},{"date":"2025-06-30","value":"40.10","vol":"22.01"},{"date":"2025-03-31","value":"40.23","vol":"21.19"},{"date":"2024-12-31","value":"35.05","vol":"21.94"},{"date":"2024-09-30","value":"31.57","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
40.38 | 40.10 | 40.23 | 35.05 | 31.57 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.72","vol":"0.71"},{"date":"2025-06-30","value":"0.71","vol":"0.58"},{"date":"2025-03-31","value":"0.71","vol":"0.56"},{"date":"2024-12-31","value":"0.57","vol":"0.55"},{"date":"2024-09-30","value":"0.49","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.72 | 0.71 | 0.71 | 0.57 | 0.49 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.48","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.65","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.60","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]